DelistingMay 4, 2026, 05:31 PM
Hoth Therapeutics receives Nasdaq delisting notice for bid price
AI Summary
Hoth Therapeutics, Inc. received a notification from Nasdaq on April 30, 2026, indicating non-compliance with the minimum bid price requirement of $1.00 per share. The company's common stock traded below this threshold for 30 consecutive business days between March 18 and April 29, 2026. Hoth Therapeutics has 180 calendar days, until October 27, 2026, to regain compliance by maintaining a closing bid price of at least $1.00 for 10 consecutive business days. The company is considering options, including a reverse stock split, to address the deficiency.
Key Highlights
- Hoth Therapeutics received a Nasdaq notification on April 30, 2026, for non-compliance with the minimum bid price rule.
- The company's common stock traded below $1.00 per share for 30 consecutive business days.
- The non-compliance period was from March 18, 2026, to April 29, 2026.
- Hoth Therapeutics has 180 calendar days, until October 27, 2026, to regain compliance.
- To comply, the stock must close at or above $1.00 for a minimum of 10 consecutive business days.
- The company is considering options, including a reverse stock split, to regain compliance.